Product analysis
No Flush Niacin 500 mg is an inexpensive option for supplying niacin when intake is low. The named no-flush form should not be assumed to provide the cardiovascular effects associated with other niacin preparations.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality93
Inositol hexaniacinate clearly identifies the niacin preparation. Reliable form-quality information is unavailable for its separately listed inositol contribution.
Ingredient Transparency100
The amounts and forms of both listed actives are disclosed. That makes the preparation easier to distinguish from other types of niacin.
Value For Money100
The full serving offers favorable value for its named niacin preparation. That price advantage does not establish extra skin or cardiovascular benefit.
Customer Satisfaction81
Customer feedback is strongly positive. Several hundred ratings provide a useful base of customer feedback.
Product Focus31
The clearest role is nutritional support for normal skin maintenance when intake is low. The no-flush form cannot be treated as equivalent to other niacin preparations for cardiovascular purposes.
- Format
Capsule - Container
- 90 Capsule(s)
- Per serving
- $0.17
- Customer rating
- 4.7 · 970 ratings
Goals
No Flush Niacin declares 500 mg of inositol hexaniacinate per serving, but that form is not counted for this cardiovascular goal in the saved profile. As a result, no ingredient reaches an effective counted amount and the product has no pathway coverage here. That does not establish that the product is clinically ineffective.
How this product is rated for Cardiovascular Support
Ingredient fit28
Goal fit
Dose adequacy
Pathways0
Depth
Breadth
Evidence0
Evidence strength
Studied preparation
Formulation logic35
Partner coverage
Conflicts
Effective doses
Niacin contributes to normal skin maintenance when intake is inadequate. The 500 mg declaration has full dose support in the saved assessment, while the no-flush description does not establish added skin benefit or equivalence to the preparations used for other niacin-related outcomes.
How this product is rated for Skin Health
Ingredient fit82
Goal fit
Dose adequacy
Pathways0
Depth
Breadth
Evidence61
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Niacin (Inositol Hexaniacinate) | 500 mg | |
Inositol (Inositol Hexaniacinate) | 120 mg |
How this ingredient is rated
Active Ingredient Quality & Bioavailability57
Niacin Form & Goal Alignment
Precursor Source Quality
Dose, Safety & Label Transparency75
Clarity of Chemical Form
Form-Specific Dosage Efficacy
Flush Risk & Safety Labeling
Value100
Price Per Effective Serving
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- The current state of niacin in cardiovascular disease prevention: a systematic review and meta-regression.
- Effects of niacin on apo A1 and B levels: a systematic review and meta-analysis of randomised controlled trials.
- Effect of lipid-lowering therapies on lipoprotein(a) levels: a comprehensive meta-analysis of randomized controlled trials.
- Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol. Niaspan-Gemfibrozil Study Group.
- Equivalent efficacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemia.
- The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer.
- Niacinamide: A B vitamin that improves aging facial skin appearance.
- The clinical anti-aging effects of topical kinetin and niacinamide in Asians: a randomized, double-blind, placebo-controlled, split-face comparative trial.
- A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention.
- Nicotinamide for Skin Cancer Chemoprevention.